Aripiprazole in the treatment of schizophrenia: safety and tolerbility in short-term, placebo-controlled trials. - Marder,S.R.; McQuade,R.D.; Stock,E.; Kaplita,S.; Marcus,R.; Safferman,A.Z.; Saha,A.; Ali,M.; Iwamoto,T. (Schizophr Res, 2003)